D. Matthew Shoemaker

420 total citations
10 papers, 301 citations indexed

About

D. Matthew Shoemaker is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, D. Matthew Shoemaker has authored 10 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in D. Matthew Shoemaker's work include Drug-Induced Adverse Reactions (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Ethics in Clinical Research (1 paper). D. Matthew Shoemaker is often cited by papers focused on Drug-Induced Adverse Reactions (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Ethics in Clinical Research (1 paper). D. Matthew Shoemaker collaborates with scholars based in United States. D. Matthew Shoemaker's co-authors include William Salzer, John Williamson, Dima Dandachi, Rebecca Reece, Nathan C. Bahr, Karen Snyder, Charles K. Grieshaber, Daniel F. Hoth, Mary K. Wolpert-DeFilippes and Richard B. Moon and has published in prestigious journals such as Clinical Infectious Diseases, Vector-Borne and Zoonotic Diseases and The Journal of Rural Health.

In The Last Decade

D. Matthew Shoemaker

9 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Matthew Shoemaker United States	5	176	86	74	61	54	10	301
Athena L V Hobbs United States	10	121 0.7×	129 1.5×	93 1.3×	65 1.1×	27 0.5×	31	355
Sonya Tang Girdwood United States	10	168 1.0×	112 1.3×	49 0.7×	123 2.0×	25 0.5×	49	380
W. Cliff Rutter United States	11	255 1.4×	126 1.5×	144 1.9×	90 1.5×	115 2.1×	24	402
Matthias Gijsen Belgium	11	218 1.2×	115 1.3×	53 0.7×	59 1.0×	26 0.5×	32	307
S. J. Haworth United Kingdom	10	301 1.7×	120 1.4×	74 1.0×	118 1.9×	46 0.9×	11	449
Saiping Jiang China	6	143 0.8×	88 1.0×	40 0.5×	73 1.2×	21 0.4×	10	247
Ryan L. Crass United States	12	315 1.8×	132 1.5×	160 2.2×	136 2.2×	35 0.6×	33	485
Rebecca S. Pettit United States	14	201 1.1×	150 1.7×	35 0.5×	123 2.0×	23 0.4×	40	544
Joseph J. Carreno United States	13	142 0.8×	125 1.5×	159 2.1×	46 0.8×	37 0.7×	22	369
Helmi Sulaiman Malaysia	8	216 1.2×	185 2.2×	90 1.2×	115 1.9×	15 0.3×	32	493

Countries citing papers authored by D. Matthew Shoemaker

Since Specialization

Citations

This map shows the geographic impact of D. Matthew Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Matthew Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Matthew Shoemaker more than expected).

Fields of papers citing papers by D. Matthew Shoemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Matthew Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Matthew Shoemaker. The network helps show where D. Matthew Shoemaker may publish in the future.

Co-authorship network of co-authors of D. Matthew Shoemaker

This figure shows the co-authorship network connecting the top 25 collaborators of D. Matthew Shoemaker. A scholar is included among the top collaborators of D. Matthew Shoemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Matthew Shoemaker. D. Matthew Shoemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Hawkinson, Dana, et al.. (2024). Myiasis as a Vector for Bacteremia: A Unique Case of Helcococcus kunzii and Ignatzschineria ureiclastica/larvae Polymicrobial Bacteremia from Myiasis. Vector-Borne and Zoonotic Diseases. 24(11). 788–791. 2 indexed citations

Bahr, Nathan C., et al.. (2023). Pneumocystis jiroveciiInfections Among COVID-19 Patients: A Case Series and Literature Review. Open Forum Infectious Diseases. 10(2). ofad043–ofad043. 11 indexed citations

Shoemaker, D. Matthew, et al.. (2023). 1178. The Dalba Diary: A Retrospective Review of Dalbavancin Use, Clinical Outcomes, and Treatment Adherence Challenges at an Academic Medical Center. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Liesman, Rachael M., et al.. (2022). Disseminated Infection Due to Neocosmospora (Fusarium) falciformis in a patient with Acute Myelogenous Leukemia. Kansas Journal of Medicine. 15(1). 67–69.

Moore, Andrew, et al.. (2022). Systemic loxoscelism induced warm autoimmune hemolytic anemia: clinical series and review. Hematology. 27(1). 543–554. 4 indexed citations

Dandachi, Dima, et al.. (2020). Treating COVID‐19 in Rural America. The Journal of Rural Health. 37(1). 205–206. 23 indexed citations

Shoemaker, D. Matthew, et al.. (2006). A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections. Therapeutics and Clinical Risk Management. 2(2). 169–174. 29 indexed citations

Shoemaker, D. Matthew, et al.. (2006). Reply to Scheetz et al. and to Meyer and Thalhammer. Clinical Infectious Diseases. 42(3). 437–438. 1 indexed citations

Williamson, John, et al.. (2005). Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy. Clinical Infectious Diseases. 41(8). 1159–1166. 208 indexed citations

10.

Leyland-Jones, B, Daniel F. Hoth, D. Matthew Shoemaker, et al.. (1986). Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.. PubMed. 70(8). 991–6. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact